Back to state act
Description
On 3 December 2020, the Norwegian Medicines Agency introduced an export ban on rivaroxaban (20mg, 28pcs), immunoglobulins (IOVIG 100MG/ML, 300 ml hgl) and formoterol & budesonide. The export ban w...
Sign in to see full description
Intervention Details
Intervention Type
Export ban
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
03 Dec 2020
Revocation date
28 Jan 2021
Implementation level
National
Affected flow
Outward
Announced as temporary
Yes
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 5 products
Threads
See all
This intervention is not part of any Thread yet.